SKAN Group AG Share Price

Equities

SKAN

CH0013396012

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 16:31:30 26/04/2024 BST 5-day change 1st Jan Change
82 CHF +0.61% Intraday chart for SKAN Group AG +5.13% +1.49%

Financials

Sales 2024 * 390M 427M 34.09B Sales 2025 * 462M 506M 40.38B Capitalization 1.84B 2.02B 161B
Net income 2024 * 40M 43.8M 3.5B Net income 2025 * 54M 59.13M 4.72B EV / Sales 2024 * 4.42 x
Net cash position 2024 * 122M 134M 10.67B Net cash position 2025 * 132M 145M 11.57B EV / Sales 2025 * 3.71 x
P/E ratio 2024 *
45.4 x
P/E ratio 2025 *
33.9 x
Employees 1,428
Yield 2024 *
0.73%
Yield 2025 *
1%
Free-Float 47.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.61%
1 week+5.13%
Current month-3.64%
1 month-3.64%
3 months+3.93%
6 months+22.39%
Current year+1.49%
More quotes
1 week
78.20
Extreme 78.2
82.00
1 month
75.70
Extreme 75.7
85.40
Current year
72.90
Extreme 72.9
85.40
1 year
65.00
Extreme 65
88.60
3 years
33.00
Extreme 33
95.19
5 years
8.80
Extreme 8.8
95.19
10 years
5.50
Extreme 5.5
95.19
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 31/12/08
Director of Finance/CFO 42 31/12/17
Chief Tech/Sci/R&D Officer 58 31/03/22
Members of the board TitleAgeSince
Director/Board Member 62 03/10/21
Director/Board Member 47 03/10/21
Chief Executive Officer 58 31/12/08
More insiders
Date Price Change Volume
26/04/24 82 +0.61% 8,598
25/04/24 81.5 +0.62% 40,426
24/04/24 81 -0.61% 20,492
23/04/24 81.5 +4.62% 18,233
22/04/24 77.9 -0.13% 22,448

Delayed Quote Swiss Exchange, April 26, 2024 at 04:31 pm

More quotes
SKAN Group AG, former BV Holding AG, is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
82 CHF
Average target price
91.33 CHF
Spread / Average Target
+11.38%
Consensus

Annual profits - Rate of surprise